These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
519 related articles for article (PubMed ID: 35739504)
1. A novel pyroptosis-related lncRNA prognostic signature associated with the immune microenvironment in lung squamous cell carcinoma. Zhou W; Zhang W BMC Cancer; 2022 Jun; 22(1):694. PubMed ID: 35739504 [TBL] [Abstract][Full Text] [Related]
2. Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinoma. Zhan X; Li J; Ding Y; Zhou F; Zeng R; Lei L; Zhang Y; Feng A; Qu Y; Yang Z Clin Exp Med; 2024 Jul; 24(1):145. PubMed ID: 38960987 [TBL] [Abstract][Full Text] [Related]
3. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma. Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719 [TBL] [Abstract][Full Text] [Related]
4. Identification of pyroptosis-related long non-coding RNAs with prognosis and therapy in lung squamous cell carcinoma. Zhang Y; Wang Y; Yin X; Huang Y Sci Rep; 2022 Jul; 12(1):11206. PubMed ID: 35778526 [TBL] [Abstract][Full Text] [Related]
5. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma. Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376 [TBL] [Abstract][Full Text] [Related]
6. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
7. Integrative Analysis of Pyroptosis-Related Prognostic Signature and Immunological Infiltration in Lung Squamous Cell Carcinoma. Luo P; Jiang Y; Ding S; Jiang S; Tang R; Tang Z Biomed Res Int; 2022; 2022():4944758. PubMed ID: 35692583 [TBL] [Abstract][Full Text] [Related]
8. Risk stratification and prognosis prediction based on inflammation-related gene signature in lung squamous carcinoma. Zhai W; Chen S; Duan F; Wang J; Zhao Z; Lin Y; Rao B; Wang Y; Zheng L; Long H Cancer Med; 2023 Feb; 12(4):4968-4980. PubMed ID: 36056909 [TBL] [Abstract][Full Text] [Related]
9. Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma. Mao G; Yang D; Liu B; Zhang Y; Ma S; Dai S; Wang G; Tang W; Lu H; Cai S; Zhu J; Yang H Respir Res; 2023 Jul; 24(1):176. PubMed ID: 37415224 [TBL] [Abstract][Full Text] [Related]
10. Prediction of lung squamous cell carcinoma immune microenvironment and immunotherapy efficiency with pyroptosis-derived genes. Deng X; Wang Z; Luo Y; Li Z; Chen L Medicine (Baltimore); 2022 Sep; 101(37):e30304. PubMed ID: 36123889 [TBL] [Abstract][Full Text] [Related]
11. A Novel Pyroptosis-Related Gene Signature for Early-Stage Lung Squamous Cell Carcinoma. Li X; He J Int J Gen Med; 2021; 14():6439-6453. PubMed ID: 34675612 [TBL] [Abstract][Full Text] [Related]
12. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration. Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R Front Immunol; 2022; 13():854785. PubMed ID: 35392086 [TBL] [Abstract][Full Text] [Related]
13. Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma. Huang Q; Yan J; Jiang Q; Guo F; Mo L; Deng T Medicine (Baltimore); 2023 Feb; 102(6):e32793. PubMed ID: 36820554 [TBL] [Abstract][Full Text] [Related]
14. A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma. Song J; Sun Y; Cao H; Liu Z; Xi L; Dong C; Yang R; Shi Y Bioengineered; 2021 Dec; 12(1):5932-5949. PubMed ID: 34488540 [TBL] [Abstract][Full Text] [Related]
15. Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index. Wu R; Ma R; Duan X; Zhang J; Li K; Yu L; Zhang M; Liu P; Wang C Front Immunol; 2023; 14():1236444. PubMed ID: 37841237 [TBL] [Abstract][Full Text] [Related]
16. A pyroptosis-related lncRNA signature in bladder cancer. Wang P; Wang Z; Zhu L; Sun Y; Castellano L; Stebbing J; Yu Z; Peng L Cancer Med; 2023 Mar; 12(5):6348-6364. PubMed ID: 36237132 [TBL] [Abstract][Full Text] [Related]
17. A cuproptosis-associated long non-coding RNA signature for the prognosis and immunotherapy of lung squamous cell carcinoma. Hou C; Wu X; Li C; Wang C; Liu J; Luo Q Biomol Biomed; 2023 Jul; 23(4):624-633. PubMed ID: 36724022 [TBL] [Abstract][Full Text] [Related]
18. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma. Wu L; Liu G; He YW; Chen R; Wu ZY Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952 [TBL] [Abstract][Full Text] [Related]
19. A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinoma. Yang Q; Gong H; Liu J; Ye M; Zou W; Li H Sci Rep; 2022 Aug; 12(1):13646. PubMed ID: 35953696 [TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on T-cell marker genes to predict prognosis and therapeutic response in lung squamous cell carcinoma. Shi X; Dong A; Jia X; Zheng G; Wang N; Wang Y; Yang C; Lu J; Yang Y Front Immunol; 2022; 13():992990. PubMed ID: 36311764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]